Cargando…
Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice
We tested the hypothesis that voluntary wheel running would complement microdystrophin gene therapy to improve muscle function in young mdx mice, a model of Duchenne muscular dystrophy. mdx mice injected with a single dose of AAV9-CK8-microdystrophin or vehicle at age 7 weeks were assigned to three...
Autores principales: | Hamm, Shelby E., Fathalikhani, Daniel D., Bukovec, Katherine E., Addington, Adele K., Zhang, Haiyan, Perry, Justin B., McMillan, Ryan P., Lawlor, Michael W., Prom, Mariah J., Vanden Avond, Mark A., Kumar, Suresh N., Coleman, Kirsten E., Dupont, J.B., Mack, David L., Brown, David A., Morris, Carl A., Gonzalez, J. Patrick, Grange, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020351/ https://www.ncbi.nlm.nih.gov/pubmed/33850950 http://dx.doi.org/10.1016/j.omtm.2021.02.024 |
Ejemplares similares
-
Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice
por: Hamm, Shelby E., et al.
Publicado: (2021) -
Prolonged voluntary wheel running reveals unique adaptations in mdx mice treated with microdystrophin constructs ± the nNOS-binding site
por: Hamm, S. E., et al.
Publicado: (2023) -
Voluntary wheel running in dystrophin-deficient (mdx) mice: Relationships between exercise parameters and exacerbation of the dystrophic phenotype
por: Smythe, Gayle M, et al.
Publicado: (2012) -
Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery
por: Hersh, Jessica, et al.
Publicado: (2021) -
Microdystrophin Expression as a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials
por: Chamberlain, Jeffrey S., et al.
Publicado: (2023)